<- Go Home
LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Market Cap
$68.1M
Volume
91.4K
Cash and Equivalents
$12.5M
EBITDA
-$11.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$26.4M
Profit Margin
45.71%
52 Week High
$14.20
52 Week Low
$5.06
Dividend
N/A
Price / Book Value
6.31
Price / Earnings
2.47
Price / Tangible Book Value
11.69
Enterprise Value
$71.0M
Enterprise Value / EBITDA
-6.39
Operating Income
-$16.4M
Return on Equity
362.55%
Return on Assets
-14.73
Cash and Short Term Investments
$13.5M
Debt
$2.6M
Equity
$24.6M
Revenue
$57.7M
Unlevered FCF
-$17.2M
Sector
Health Care Equipment and Supplies
Category
N/A